Note 1 - Organization and Nature of Operations

12 Months Ended

Dec. 31, 2016

Notes to Financial Statements

Nature of Operations [Text Block]

NOTE

1:

ORGANIZATION AND NATURE OF OPERATIONS

OmniComm Systems, Inc. (“OmniComm” or the “Company”) is a healthcare te

chnology company that provides web-based electronic data capture (“EDC”) solutions and related value-added services to pharmaceutical and biotechnology companies, clinical research organizations(“CROs”), and other clinical trial sponsors principally located in the United States, Europe and East Asia. Our proprietary EDC software applications; TrialMaster

®

; TrialOne

®

; Promasys

®

; and eClinical Suite, allow clinical trial sponsors and investigative sites to securely collect, validate, transmit, and analyze clinical trial data.

Our ability to compete within the EDC industry is predicated on our ability to continue enhancing and broadening the scope of solutions offered through our EDC software and services.

  Our

research and product development

efforts are focused on developing new and complementary software solutions, as well as enhancing our existing software solutions, through the addition of increased functionality.  During the years ended

December

31,

2016

and

December

31,

2015

we spent approximately

$2,598,962

and

$2,639,577,

respectively, on

research and product development

activities, which is primarily comprised of salaries to our developers and other

research and product development

personnel and related costs associated with the development of our software products